The pandemic has revealed some inadequacies in the way medical device suppliers manage regulated product information. The following is a look back on a challenging year and suggestions for practical improvements to cope with continued uncertainty in 2021.
In order to meet the worldwide need for faster and affordable testing processes, companies must shift goals and apply resources to ending this pandemic.
The continued threat and spread of COVID-19 across the globe has led to seismic uncertainty for every industry.
Don’t miss this opportunity to learn how your company can effectively push its product to the finish line.
Launched by AdvaMed, the platform was developed in collaboration with partners that include the Aerospace Industries Association and Google.
Across the continent, governments and hospitals are purchasing robotics systems from abroad as well as developing the technologies themselves.
Sharing more information with design partners on device function and its inherent risks can help guide better decisions during the product development process, and keep patients safer.
The program intends to promote quality in medical device design and manufacturing.
A look at some common mistakes medical device companies make when approaching risk.
The company will invest €13 million in the facility, which will make drug-coated balloons for peripheral artery disease.